FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Drug Delivery News

FierceDrugDelivery covers the bio/pharmaceutical drug delivery market. Find news on nanoparticles, cancer drug delivery, FDA recalls and more. For more information and analysis on these topics, please visit our biotechnology reports.

Impax licenses U.S. rights to AstraZeneca migraine drug, variations likely

Impax Pharmaceuticals is paying AstraZeneca ($AZN) $130 million so it can license U.S. commercial rights for three versions of the migraine drug Zomig. Their agreement also allows for new variations Read more >>

Engineers develop concentrated proteins to simplify, transform drug delivery

Right now, protein biopharmaceuticals are fairly diluted and administered intravenously at a hospital. A group of researchers from The University of Texas at Austin promise to transform the nature of Read more >>

AMT's Glybera, delivered through virus, faces Euro reg delay

European regulators have slammed on the breaks and delayed an approval decision for Amsterdam Molecular Therapeutics' Glybera, a gene therapy delivered by an altered virus for patients with a rare Read more >>

Amylin gets FDA OK for weekly diabetes drug Bydureon

Say hello to Bydureon, a once-weekly injectable treatment for Type 2 diabetes finally approved by the FDA on Jan. 27. Amylin Pharmaceuticals ($AMLN) developed the drug using controlled release drug Read more >>

Takeda abandons Euro rights to Durect's controlled-release pain drug

For the second time this year, Durect ($DRRX) faces a setback over its controlled-release anti-pain drug Posidur. The Cupertino, CA-based company disclosed that its European development and marketing Read more >>

New drug delivery system slows water filtration, displaces air

Scientists at Brigham and Women's Hospital in Boston and Boston University have concocted a new drug delivery mechanism that could work over a period of months, carrying a pain or cancer treatment. Read more >>

Nanotech transforms cyclosporine into safer transplant drug

Scientists are eyeing nanotech drug delivery as a way to help reduce organ transplant failures. The Times of India reports that researchers at the University of Strathclyde in Scotland are working on Read more >>

Report: Roche transferring Israeli diabetes operations to Europe

Less than two years after paying $200 million for diabetes pump developer Medingo, Roche's diagnostic division ($RHHBY) is shutting down the company and transferring its operations from Israel to Read more >>

This could be the year of nanotech-enabled medicines

Nanotech-enabled medicines are coming of age. That's the big message I came away with after a recent telephone chat with Kevin Bitterman, a life sciences investor with Polaris Venture Partners in Read more >>

University of Arkansas heightens nanomedicine research efforts

Another player is joining the field of nanomedicine-related research and development: The Arkansas Nanomedicine Center. To be housed at The University of Arkansas' College of Medicine, the new Read more >>

Alexza's Adasuve slapped with delayed FDA review

The FDA slammed Alexza Pharmaceuticals ($ALXA) with another setback this week in its drive to bring the antipsychotic drug Adasuve to market. Regulators are extending by three months their review of Read more >>

Mylan concocts ready-to-use epilepsy drug variation

Global generic drug manufacturer Mylan ($MYL) has begun selling a version of the anti-epilepsy drug Levetiracetam for intravenous use in a variation intended to be safer and easy to use. Doses are Read more >>

Next-gen nanoparticles deliver cancer drugs at just the right moment

Nanoparticles often deliver cancer drugs prematurely, releasing their cargo at the slightest trigger, missing their target. Researchers concocted a new version that appears able to last longer, Read more >>

Carticept nails down $10M to fuel Q1 launch of ultrasound drug delivery system

Carticept Medical will launch its new ultrasound-guided, computer-controlled drug delivery system for joint pain medications sometime during its fiscal 2012 first quarter, fueled by a new, $10 Read more >>

Bioject mulls options including possible sale

Bioject Medical Technologies ($BJCT) has hired a financial adviser to explore the always-ominous "strategic alternatives." One option for the maker of needle-free drug delivery systems: selling the Read more >>